Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential

Tyndall, 2003, Haematopoietic stem cell transplantation for the treatment of systemic sclerosis and other autoimmune disorders, Expert Opinion on Biological Therapy, 3, 1041, 10.1517/14712598.3.7.1041 Storb, 2003, Hematopoietic cell transplantation for benign hematological disorders and solid tumors, Hematology (American Society of Hematology Educational Program), 372, 10.1182/asheducation-2003.1.372 Lyons, 2002, Gene-expression profiling and the genetic dissection of complex disease, Current Opinion in Immunology, 14, 627, 10.1016/S0952-7915(02)00383-7 Robinson, 2002, Autoantigen microarrays for multiplex characterization of autoantibody responses, Nature Medicine, 8, 295, 10.1038/nm0302-295 Radich, 2001, The significance of bcr-abl molecular detection in chronic myeloid leukemia patients ‘late,’ 18 months or more after transplantation, Blood, 98, 1701, 10.1182/blood.V98.6.1701 Kita, 2003, Application of tetramer technology in studies on autoimmune diseases, Autoimmunity Reviews, 2, 43, 10.1016/S1568-9972(02)00124-6 Sun, 2004, Characteristics of T cell receptor repertoire and myelin-reactive T cells reconstituted from autologous hematopoietic stem cell grafts in multiple sclerosis, Brain, 10.1093/brain/awh117 Van Bekkum, 2002, Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseases, Journal of Leukocyte Biology, 72, 609, 10.1189/jlb.72.4.609 Ikehara, 2001, Treatment of autoimmune diseases by hematopoietic stem cell transplantation, Experimental Hematology, 29, 661, 10.1016/S0301-472X(01)00645-2 Storb, 2003, Allogeneic hematopoietic stem cell transplantation—yesterday, today, and tomorrow, Experimental Hematology, 31, 1, 10.1016/S0301-472X(02)01020-2 Khouri, 2002, Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy, Cancer Treatment and Research, 110, 137, 10.1007/978-1-4615-0919-6_7 Kottaridis, 2000, In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation [in process citation], Blood, 96, 2419, 10.1182/blood.V96.7.2419 Krance, 2003, Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy, Biology of Blood and Marrow Transplantation, 9, 273, 10.1053/bbmt.2003.50024 Wulf, 2003, Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation, Blood, 101, 2434, 10.1182/blood-2002-08-2379 Gershon, 1971, Infectious immunological tolerance, Immunology, 21, 903 Moller, 1988, Do suppressor T cells exist?, Scandinavian Journal of Immunology, 27, 247, 10.1111/j.1365-3083.1988.tb02344.x Janeway, 1988, Do suppressor T cells exist? A reply, Scandinavian Journal of Immunology, 27, 621, 10.1111/j.1365-3083.1988.tb02392.x Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, Journal of Immunology, 155, 1151, 10.4049/jimmunol.155.3.1151 Gavin, 2002, Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo, Nature Immunology, 3, 33, 10.1038/ni743 Kohm, 2002, Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis, Journal of Immunology, 169, 4712, 10.4049/jimmunol.169.9.4712 Takahashi, 2000, Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4, Journal of Experimental Medicine, 192, 303, 10.1084/jem.192.2.303 Thornton, 1998, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, Journal of Experimental Medicine, 188, 287, 10.1084/jem.188.2.287 Dieckmann, 2001, Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood, Journal of Experimental Medicine, 193, 1303, 10.1084/jem.193.11.1303 Jonuleit, 2001, Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, Journal of Experimental Medicine, 193, 1285, 10.1084/jem.193.11.1285 Ng, 2001, Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells, Blood, 98, 2736, 10.1182/blood.V98.9.2736 Stephens, 2001, Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro, European Journal of Immunology, 31, 1247, 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M Jordan, 2001, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide, Nature Immunology, 2, 301, 10.1038/86302 Schwartz, 1996, Models of T cell anergy: is there a common molecular mechanism?, Journal of Experimental Medicine, 184, 1, 10.1084/jem.184.1.1 Miller, 1996, Mechanisms of tolerance to self, Current Opinion in Immunology, 8, 815, 10.1016/S0952-7915(96)80010-0 Zinkernagel, 1997, Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity, Immunology Review, 156, 199, 10.1111/j.1600-065X.1997.tb00969.x Baecher-Allan, 2001, CD4+CD25high regulatory cells in human peripheral blood, Journal of Immunology, 167, 1245, 10.4049/jimmunol.167.3.1245 Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, Journal of Immunology, 164, 183, 10.4049/jimmunol.164.1.183 Verneris, 2002, Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice, Journal of Clinical Immunology, 22, 131, 10.1023/A:1015415928521 Zeng, 2003, Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus, Journal of Clinical Investigation, 112, 1211, 10.1172/JCI200317165 Yamagiwa, 2001, A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood, Journal of Immunology, 166, 7282, 10.4049/jimmunol.166.12.7282 Masuyama, 2002, A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells, Journal of Immunology, 169, 3710, 10.4049/jimmunol.169.7.3710 Zheng, 2002, Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25− precursors, Journal of Immunology, 169, 4183, 10.4049/jimmunol.169.8.4183 Gilliet, 2002, Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells, Journal of Experimental Medicine, 195, 695, 10.1084/jem.20011603 Liu, 1998, Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28− T cells, International Immunology, 10, 775, 10.1093/intimm/10.6.775 Dhodapkar, 2002, Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans, Blood, 100, 174, 10.1182/blood.V100.1.174 Zhang, 2000, Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nature Medicine, 6, 782, 10.1038/77513 Weiner, 2001, Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells, Immunology Review, 182, 207, 10.1034/j.1600-065X.2001.1820117.x Weiner, 2001, Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells, Microbes and Infection, 3, 947, 10.1016/S1286-4579(01)01456-3 Sosroseno, 2003, Induction of suppressor cells following mucosal presentation of Actinomyces viscosus in mice, Oral Microbiology and Immunology, 18, 318, 10.1034/j.1399-302X.2003.00093.x Waldmann, 1998, How do monoclonal antibodies induce tolerance? A role for infectious tolerance?, Annual Review of Immunology, 16, 619, 10.1146/annurev.immunol.16.1.619 Qin, 1993, ‘Infectious’ transplantation tolerance, Science, 259, 974, 10.1126/science.8094901 Taylor, 2002, Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell, Blood, 99, 4601, 10.1182/blood.V99.12.4601 Graca, 2000, Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance, Journal of Immunology, 165, 4783, 10.4049/jimmunol.165.9.4783 Rudd, 2003, Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling, Nature Reviews. Immunology, 3, 544, 10.1038/nri1131 Wakkach, 2001, Differentiation of regulatory T cells 1 is induced by CD2 costimulation, Journal of Immunology, 167, 3107, 10.4049/jimmunol.167.6.3107 Akbari, 2002, Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity, Nature Medicine, 8, 1024, 10.1038/nm745 Steinbrink, 2002, CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity, Blood, 99, 2468, 10.1182/blood.V99.7.2468 Barrat, 2002, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines, Journal of Experimental Medicine, 195, 603, 10.1084/jem.20011629 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Daley, 2003, Realistic prospects for stem cell therapeutics, Hematology (American Society of Hematology Education Program), 398, 10.1182/asheducation-2003.1.398 Jiang, 2002, Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, 418, 41, 10.1038/nature00870 Gussoni, 1999, Dystrophin expression in the mdx mouse restored by stem cell transplantation, Nature, 401, 390, 10.1038/43919 Wagers, 2002, Little evidence for developmental plasticity of adult hematopoietic stem cells, Science, 297, 2256, 10.1126/science.1074807 Alvarez-Dolado, 2003, Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes, Nature, 425, 968, 10.1038/nature02069 Wang, 2003, Cell fusion is the principal source of bone-marrow-derived hepatocytes, Nature, 422, 897, 10.1038/nature01531 Matera, 1952, [Frontal lobectomy; 28 cases of resection of the frontal lobe], El Dia medico, 24, 2142 Camargo, 2004, Corrigendum: single hematopoietic stem cells generate skeletal muscle through myeloid intermediates, Nature Medicine, 10, 105, 10.1038/nm0104-105c Wang, 2003, The origin and liver repopulating capacity of murine oval cells, Proceedings of the National Academy of Sciences of the USA, 100, 11881, 10.1073/pnas.1734199100 Fu, 2003, Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect, Molecular Therapy, 7, 748, 10.1016/S1525-0016(03)00092-3 Olmsted-Davis, 2003, Primitive adult hematopoietic stem cells can function as osteoblast precursors, Proceedings of the National Academy of Sciences of the USA, 100, 15877, 10.1073/pnas.2632959100 Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta [see comments], Nature Medicine, 5, 309, 10.1038/6529 Horwitz, 2001, Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta, Blood, 97, 1227, 10.1182/blood.V97.5.1227 Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone, Proceedings of the National Academy of Sciences of the USA, 99, 8932, 10.1073/pnas.132252399 Hirschi, 2002, Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells, Gene Therapy, 9, 648, 10.1038/sj.gt.3301722 Jackson, 2001, Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells, Journal of Clinical Investigation, 107, 1395, 10.1172/JCI12150 Raper, 2003, Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer, Molecular Genetics and Metabolism, 80, 148, 10.1016/j.ymgme.2003.08.016 Hacein-Bey-Abina, 2003, A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency, New England Journal of Medicine, 348, 255, 10.1056/NEJM200301163480314 Kohn, 2003, Occurrence of leukaemia following gene therapy of X-linked SCID, Nature Reviews. Cancer, 3, 477, 10.1038/nrc1122 Brenner, 2002, Evidence-based regulation—a personal view, Molecular Therapy, 6, 137, 10.1006/mthe.2002.0644 Robbins, 2003, Gene therapy for arthritis, Gene Therapy, 10, 902, 10.1038/sj.gt.3302040 Evans, 1997, Getting genes into human synovium, Journal of Rheumatology, 24, 2061 Nakajima, 2001, Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis, Journal of Clinical Investigation, 107, 1293, 10.1172/JCI12037 Chernajovsky, 1995, Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor, Gene Therapy, 2, 731 Chernajovsky, 1997, Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model, Gene Therapy, 4, 553, 10.1038/sj.gt.3300436 Dreja, 2000, Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis, Arthritis and Rheumatism, 43, 1698, 10.1002/1529-0131(200008)43:8<1698::AID-ANR5>3.0.CO;2-8 Kim, 2001, Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4, Journal of Immunology, 166, 3499, 10.4049/jimmunol.166.5.3499 Studeny, 2002, Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors, Cancer Research, 62, 3603 Bessis, 2002, Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis, Journal of Gene Medicine, 4, 300, 10.1002/jgm.275 Rabinovich, 1999, Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis, Journal of Experimental Medicine, 190, 385, 10.1084/jem.190.3.385